Chemoinformaics analysis of Benzyl isoamyl ether
| Molecular Weight | 178.275 | nRot | 5 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 6 |
| Exact Molecular Weight | 178.136 | nRing | 1 |
| Solubility: LogS | -3.669 | nHRing | 0 |
| Solubility: LogP | 3.677 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 32.8443 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.629 |
| Synth | 1.514 |
| Natural Product Likeliness | -0.506 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.004 |
| HIA | 0.002 |
| CACO-2 | -4.166 |
| MDCK | 0.0000464 |
| BBB | 0.705 |
| PPB | 0.923337 |
| VDSS | 1.79 |
| FU | 0.0607176 |
| CYP1A2-inh | 0.811 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.768 |
| CYP2c19-sub | 0.379 |
| CYP2c9-inh | 0.632 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.288 |
| CL | 10.739 |
| T12 | 0.498 |
| hERG | 0.073 |
| Ames | 0.017 |
| ROA | 0.036 |
| SkinSen | 0.522 |
| Carcinogencity | 0.427 |
| EI | 0.991 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.676258 |